SPX4,297.14+16.99 0.40%
DIA339.37+1.54 0.46%
IXIC13,128.05+80.87 0.62%

GSK says U.S. FDA approves kidney disease drug for children

GSK says U.S. FDA approves kidney disease drug for children

Reuters · 07/27/2022 13:30
GSK says U.S. FDA approves kidney disease drug for children

- GSK Plc GSK.N on Wednesday said the U.S. Food and Drug Administration had approved its drug Benlysta for the treatment of children aged 5 to 17 years with a type of kidney inflammation called lupus .


(Reporting by Amruta Khandekar; Editing by Devika Syamnath)

((Amruta.Khandekar@thomsonreuters.com;))